These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1363291)

  • 1. [Pharmacologic profile of dithiadenoxide, a potential non-sedating H1-antihistaminic].
    Blehová H; Metys J
    Cesk Farm; 1992 Sep; 41(6):185-90. PubMed ID: 1363291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacological properties of the antihistaminic, dithiaden].
    Metys J; Metysová J
    Cesk Farm; 1971 Sep; 20(7):251-6. PubMed ID: 4398668
    [No Abstract]   [Full Text] [Related]  

  • 3. [Densitometric determination of dithiadenoxide in blood].
    Peterková M; Matousová O
    Cesk Farm; 1993 Apr; 42(2):86-7. PubMed ID: 8104717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A comparative pharmacologic study of histamine H-1 antagonists].
    Blehová H; Metys J; Soucek R; Valchár M
    Cesk Farm; 1991 Apr; 40(2):67-70. PubMed ID: 1680029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Some pharmacodynamical properties of niaprazine, a new antihistaminic agent].
    Duchene-Marullaz P; Rispat G; Perriere JP; Hache J; Labrid C
    Therapie; 1971; 26(6):1203-9. PubMed ID: 4401719
    [No Abstract]   [Full Text] [Related]  

  • 6. Some pharmacologic characteristics of a new antihistaminic (SQ 10,648), 11-(2-dimethylaminoethyl)-6,11-dihydrodibenz-[b,e] [1,4] oxazepine maleate.
    Rubin B; Piala JJ; Millonig R; Craver BN
    Arch Int Pharmacodyn Ther; 1965 May; 155(1):47-56. PubMed ID: 4378646
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro and in vivo studies of the non-sedating antihistamine epinastine.
    Fügner A; Bechtel WD; Kuhn FJ; Mierau J
    Arzneimittelforschung; 1988 Oct; 38(10):1446-53. PubMed ID: 2461715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal pharmacology of the selective histamine H1-receptor antagonist tazifylline.
    Poizot A; Dumez D; Ferrandon P; Lefournier C; Michel A; Armstrong JM
    Arzneimittelforschung; 1986 Apr; 36(4):695-702. PubMed ID: 2424463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The H1-histamine receptor antagonist dithiaden inhibits stimulated platelet aggregation, malondialdehyde formation and thromboxane production in vitro.
    Nosál R; Jancinová V; Petríková M
    Inflamm Res; 1995 Apr; 44 Suppl 1():S14-5. PubMed ID: 8520978
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of histamine injected in cerebral ventricles on the behavior of rats and mice: pharmacologic study].
    Delbarre B
    J Physiol (Paris); 1972 Oct; 65():Suppl:223A. PubMed ID: 4405480
    [No Abstract]   [Full Text] [Related]  

  • 11. [Phencarol--an antihistaminic preparation from the quinuclidylcarbinol group].
    Kaminka WE
    Farmakol Toksikol; 1977; 40(2):158-62. PubMed ID: 15861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and pharmacological activity of pyrazole derivatives with potential antihistaminic properties. I. Alkamine ethers of 1-phenyland 1-benzyl-3-methyl-5-hydroxypyrazole.
    Alberty JE; Hukki J; Laitinen P; Myry J
    Arzneimittelforschung; 1967 Feb; 17(2):214-20. PubMed ID: 4385477
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the histaminic potentiation of chloral sleep in mice. Effect of anticholinergic and antihistaminic drugs].
    Delbarre B; Harichaux P
    C R Seances Soc Biol Fil; 1967; 161(6):1441-3. PubMed ID: 4385689
    [No Abstract]   [Full Text] [Related]  

  • 14. Reactive oxygen metabolite production is inhibited by histamine and H1-antagonist dithiaden in human PMN leukocytes.
    Drábiková K; Nosál R; Jancinová V; Cíz M; Lojek A
    Free Radic Res; 2002 Sep; 36(9):975-80. PubMed ID: 12448823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The H1-histamine antagonist Dithiaden inhibits human platelets in vitro.
    Nosál R; Jancinová V; Danihelová E
    Inflamm Res; 1996 Mar; 45 Suppl 1():S29-30. PubMed ID: 8696916
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacology of the new H1-receptor antagonist setastine hydrochloride.
    Porszász J; Varga F; Porszász KG; Szolscányi J; Barthó L; Petöcz L; Kápolnai L
    Arzneimittelforschung; 1990 Dec; 40(12):1340-5. PubMed ID: 1982751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AHR-14310C: a potent, long-acting, nonsedating H1-antihistamine that prevents antigen-induced mucus formation in sensitive rats.
    Nolan JC; Foxwell MH; Whitman LL; Yanni JM; Walsh DA; Kilpatrick BF; Johnson DN; Proakis AG
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1177-83. PubMed ID: 1972750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H(1)- antihistamines and activated blood platelets.
    Petríková M; Jancinová V; Nosál R; Májeková M; Holománová D
    Inflamm Res; 2006 Apr; 55 Suppl 1():S51-2. PubMed ID: 16547813
    [No Abstract]   [Full Text] [Related]  

  • 19. Characteristics of the antihistamine effect of TAK-427, a novel imidazopyridazine derivative.
    Fukuda S; Midoro K; Yamasaki M; Gyoten M; Kawano Y; Fukui H; Ashida Y; Nagaya H
    Inflamm Res; 2003 May; 52(5):206-14. PubMed ID: 12813625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terfenadine, the first non-sedating antihistamine.
    Woodward JK; Munro NL
    Arzneimittelforschung; 1982; 32(9a):1154-6. PubMed ID: 6129860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.